---
figid: PMC3464048__nihms-406046-f0001
figlink: /pmc/articles/PMC3464048/figure/F1/
number: F1
caption: 'The intact Fas–FasL-mediated apoptosis pathway is shown. Elevated levels
  of the soluble form of Fas or FasL contribute to apoptotic resistance in leukemic
  LGLs by acting as receptor or ligand decoys. MMP inhibitors are proposed for therapeutic
  intervention. Other contributing signaling pathways that are essential in LGL leukemia
  pathogenesis include the signals that are mediated by IL-15, PDGF and NF-κB. IL-15
  promotes LGL survival either by activating the JAK–STAT3 signaling pathway to upregulate
  gene expression of antiapoptotic factor or by targeting Bid to the proteasome for
  degradation. IL-15 signaling can be inhibited by a Mikβ1 monoclonal antibody targeting
  the IL-15R. PDGF functions through PI3K–Akt and Ras–MEK1–ERK signaling cascades,
  leading to cell proliferation and growth. PDGF signaling can be inhibited by RTK
  inhibitors such as imatinib. PI3K–Akt signaling can be blocked by using pan-PI3K
  inhibitors. Ras–MEK1–ERK signaling can be targeted using farnesyltransferase inhibitors
  to prevent farnesylation of Ras or by using MEK1 inhibitors such as PD98059 and
  U0216. NF-κB complex upregulates the transcription of survival genes resulting in
  survival of leukemic LGLs. Bortezomib, a proteasome inhibitor, can be used to prevent
  NF-κB signaling. FasL: Fas ligand; IκB: Inhibitor of NF-κB; IKK: IκB kinase; IL-15R:
  IL-15 receptor; LGL: Large granular lymphocyte; MMP: Matrix metalloproteinase; RTK:
  Receptor tyrosine kinase.'
pmcid: PMC3464048
papertitle: 'Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic
  targets.'
reftext: Francis LeBlanc, et al. Future Oncol. ;8(7):787-801.
pmc_ranked_result_index: '53422'
pathway_score: 0.9733305
filename: nihms-406046-f0001.jpg
figtitle: 'Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic
  targets'
year: ''
organisms:
- Homo sapiens
ndex: 72c16fdb-dec3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3464048__nihms-406046-f0001.html
  '@type': Dataset
  description: 'The intact Fas–FasL-mediated apoptosis pathway is shown. Elevated
    levels of the soluble form of Fas or FasL contribute to apoptotic resistance in
    leukemic LGLs by acting as receptor or ligand decoys. MMP inhibitors are proposed
    for therapeutic intervention. Other contributing signaling pathways that are essential
    in LGL leukemia pathogenesis include the signals that are mediated by IL-15, PDGF
    and NF-κB. IL-15 promotes LGL survival either by activating the JAK–STAT3 signaling
    pathway to upregulate gene expression of antiapoptotic factor or by targeting
    Bid to the proteasome for degradation. IL-15 signaling can be inhibited by a Mikβ1
    monoclonal antibody targeting the IL-15R. PDGF functions through PI3K–Akt and
    Ras–MEK1–ERK signaling cascades, leading to cell proliferation and growth. PDGF
    signaling can be inhibited by RTK inhibitors such as imatinib. PI3K–Akt signaling
    can be blocked by using pan-PI3K inhibitors. Ras–MEK1–ERK signaling can be targeted
    using farnesyltransferase inhibitors to prevent farnesylation of Ras or by using
    MEK1 inhibitors such as PD98059 and U0216. NF-κB complex upregulates the transcription
    of survival genes resulting in survival of leukemic LGLs. Bortezomib, a proteasome
    inhibitor, can be used to prevent NF-κB signaling. FasL: Fas ligand; IκB: Inhibitor
    of NF-κB; IKK: IκB kinase; IL-15R: IL-15 receptor; LGL: Large granular lymphocyte;
    MMP: Matrix metalloproteinase; RTK: Receptor tyrosine kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MMP3
  - MMP2
  - MMP8
  - MMP19
  - MAPK1
  - MMP21
  - MMP7
  - MMP17
  - MMP1
  - HRAS
  - MMP16
  - KRAS
  - PDGFC
  - BID
  - RAF1
  - TYK2
  - STAT3
  - AKT2
  - MAP2K1
  - MMP9
  - MMP10
  - MAPK13
  - MAPK14
  - MMP12
  - MAPK10
  - PDGFB
  - MMP11
  - MMP15
  - NRAS
  - PIK3CA
  - MAPK12
  - MAPK8
  - MAPK3
  - MMP13
  - AKT3
  - AKT1
  - MAPK11
  - PDGFA
  - NFKB1
  - PIK3R4
  - JAK3
  - PIK3CG
  - CHUK
  - IKBKB
  - MAPK9
  - MMP27
  - PIK3R3
  - MMP14
  - JAK2
  - MMP23B
  - FADD
  - FAS
  - PDGFD
  - MTOR
  - PIK3CB
  - PIK3CD
  - FASLG
  - MMP25
  - PIK3R6
  - PIK3R5
  - JAK1
  - MMP20
  - MMP28
  - IKBKG
  - IL15
  - MMP24
  - Autoimmune lymphoproliferative syndrome
  - Cancer
genes:
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP3
  entrez: '4314'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP8
  entrez: '4317'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP19
  entrez: '4327'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP21
  entrez: '118856'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP7
  entrez: '4316'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP17
  entrez: '4326'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP16
  entrez: '4325'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: Bid
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: Raf1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MEK1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP10
  entrez: '4319'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP12
  entrez: '4321'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP11
  entrez: '4320'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP15
  entrez: '4324'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP27
  entrez: '64066'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP14
  entrez: '4323'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP23B
  entrez: '8510'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: Fas
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: PDGF)
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Fasl
  symbol: FasL
  source: hgnc_alias_symbol
  hgnc_symbol: FASLG
  entrez: '356'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP25
  entrez: '64386'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP20
  entrez: '9313'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP28
  entrez: '79148'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IL-15
  symbol: IL-15
  source: hgnc_alias_symbol
  hgnc_symbol: IL15
  entrez: '3600'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP24
  entrez: '10893'
chemicals: []
diseases:
- word: Autoimmune lymphoproliferative syndrome
  source: ''
  identifier: ''
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3464048__F1
redirect_from: /figures/PMC3464048__F1
figtype: Figure
---
